Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.2.1 Data collection
1.3 Forecast calculations
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1.1 Glucose biosensors industry 360° synopsis, 2018 - 2032 (USD Million)
2.2 Business trends
2.3 Regional trends (USD Million & Units)
2.4 Type trends (USD Million & Units)
2.5 Technology trends
2.6 End-use trends
Chapter 3 Glucose Biosensors Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of patients suffering from diabetes across the world
3.2.1.2 Rising demand for self-monitoring devices globally
3.2.1.3 Increasing government initiatives to generate awareness regarding diabetes
3.2.1.4 Technological advancements in glucose biosensor devices
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of glucose biosensors devices
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By technology
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix
Chapter 5 Glucose Biosensors Market Size and Forecast, By Type (USD Million & Units)
5.1 Key trends, by type
5.2 Continuous Glucose Monitoring (CGM)
5.3 Self-monitoring Blood Glucose (SMBG)
Chapter 6 Glucose Biosensors Market Size and Forecast, By Technology (USD Million)
6.1 Key trends, by technology
6.2 Electrochemical biosensors
6.3 Optical biosensors
Chapter 7 Glucose Biosensors Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Home healthcare
7.4 Diagnostic centres & clinics
7.5 Others
Chapter 8 Glucose Biosensors Market Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 The Netherlands
8.3.7 Switzerland
8.3.8 Poland
8.3.9 Denmark
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Thailand
8.4.8 Indonesia
8.4.9 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.)
9.2 Lifescan, Inc.
9.3 Universal Biosensors
9.4 Nova Biomedical
9.5 Med Trust
9.6 Taidoc Technology Corporation
9.7 Roche AG.
9.8 Dexcom
9.9 i-SENS, Inc.
9.10 Abbott Laboratories
9.11 Trividia Health
9.12 Pinnacle Technology
9.13 Medtronic plc
